BX7-15127-69267
2 vaccinations
2 coded responses
24 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 661 / KS
- Registered
- 2021-01-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-05
Registered in v-safe
-
2021-01-05
Dose 1 — Pfizer-BioNTech
- 2021-01-05
-
2021-01-06
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-06
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2021-01-07
- 2021-01-08
- 2021-01-09
- 2021-01-11
- 2021-01-12
- 2021-01-19
-
2021-01-26
Dose 2 — Pfizer-BioNTech
-
2021-01-26
Health check-in — day 0, dose 2Feeling: Good · Site: Pain · Headache, Muscle or body achesAdult check-in
-
2021-01-27
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-28
Survey response — days 1–6 daily, dose 2MedDRA: Axillary pain — Feeling: Good · Site: Pain · HeadacheFree text: Axillary lymph node pain--mildMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-03-09
- 2021-04-27
- 2021-07-27
-
2022-01-26
Survey response — 12 months, dose 2MedDRA: Abortion spontaneous, Office visit — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Miscarriage 12/24/21 · Healthcare visit (other): In office follow upMedDRA releases: 2024-11 · check-in free text available
-
2022-01-26
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2022-01-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-05 | Pfizer-BioNTech | |
| 2 | 2021-01-26 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-06 | priority 2/3 | |
| 2022-01-26 | Unsuccessful |
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Axillary lymph node pain--mild
Release 11 — 12 months, dose 2
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Abortion spontaneous | · | · | ✓ |
| SRO | Axillary pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release